Yong Tang

Treatment patterns and outcomes in Chinese gastric cancer patients by HER2 status: a non-interventional registry study (EVIDENCE).

J. Ji, Jianming Xu, W. Su, 2021, The Oncologist.

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.

B. Peng, Lei Yang, Y. Bai, 2023, JAMA.